Aimmune Therapeutics, Inc.

CIK 1631650 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aimmune Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Feb 16, 2021SC 13G/A0001306923-21-000011
Oct 23, 202015-12B0001193125-20-275192
Oct 19, 20208-K0001193125-20-272122
Oct 15, 202040000899243-20-028359
Oct 14, 2020EFFECT9999999995-20-002834
Oct 14, 202040000899243-20-028180
Oct 14, 202040000899243-20-028179
Oct 14, 202040000899243-20-028171
Oct 14, 202040000899243-20-028183
Oct 14, 202040000899243-20-028172
Oct 14, 202040000899243-20-028173
Oct 14, 202040000899243-20-028178
Oct 14, 202040000899243-20-028176
Oct 14, 202040000899243-20-028174
Oct 14, 202040000899243-20-028181
Oct 14, 2020EFFECT9999999995-20-002835
Oct 14, 202040000899243-20-028177
Oct 14, 202040000899243-20-028182
Oct 13, 2020S-8 POS0001193125-20-268643
Oct 13, 2020S-8 POS0001193125-20-268654
Oct 13, 2020S-8 POS0001193125-20-268649
Oct 13, 2020S-8 POS0001193125-20-268641
Oct 13, 2020POS AM0001193125-20-268640
Oct 13, 2020S-8 POS0001193125-20-268648
Oct 13, 2020SC 13D/A0001193125-20-268119